Cargando…

A year in the life of German patients with COPD: the DACCORD observational study

INTRODUCTION: Randomized interventional trials generally recruit highly selected patients. In contrast, long-term, noninterventional studies can reflect standard of care of real-life populations. DACCORD (Die ambulante Versorgung mit langwirksamen Bronchodilatatoren: COPD-Register in Deutschland [Ou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Buhl, Roland, Criée, Carl-Peter, Kardos, Peter, Vogelmeier, Claus, Lossi, Nadine, Mailänder, Claudia, Worth, Heinrich
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4959587/ https://www.ncbi.nlm.nih.gov/pubmed/27499620 http://dx.doi.org/10.2147/COPD.S112110

Ejemplares similares

“Real-life” inhaled corticosteroid withdrawal in COPD: a subgroup analysis of DACCORD
por: Vogelmeier, Claus, et al.
Publicado: (2017)

Dual bronchodilation vs triple therapy in the “real-life” COPD DACCORD study
por: Buhl, Roland, et al.
Publicado: (2018)

The Prospective Non-Interventional DACCORD Study in the National COPD Registry in Germany: design and methods
por: Kardos, Peter, et al.
Publicado: (2015)

COPD Assessment Test Changes from Baseline Correlate with COPD Exacerbations: A Longitudinal Analysis of the DACCORD Observational Study
por: Kardos, Peter, et al.
Publicado: (2020)

Impact of switching from triple therapy to dual bronchodilation in COPD: the DACCORD ‘real world’ study
por: Vogelmeier, Claus F., et al.
Publicado: (2022)

In ‘real world’ patients with COPD, exacerbation history, and not blood eosinophils, is the most reliable predictor of future exacerbations
por: Worth, Heinrich, et al.
Publicado: (2023)

Prevalence of overuse of short-acting beta-2 agonists (SABA) and associated factors among patients with asthma in Germany
por: Worth, Heinrich, et al.
Publicado: (2021)

Health status in patients with COPD treated with roflumilast: two large noninterventional real-life studies: DINO and DACOTA
por: Kardos, Peter, et al.
Publicado: (2018)

Outcome measures in chronic obstructive pulmonary disease (COPD): strengths and limitations
por: Glaab, Thomas, et al.
Publicado: (2010)

Guideline-based survey of outpatient COPD management by pulmonary specialists in Germany
por: Glaab, Thomas, et al.
Publicado: (2012)

EVELUT®: A Real-World, Observational Study Assessing Dyspnoea and Symptom Burden in COPD Patients Switched from LABA/ICS to LAMA/LABA or LAMA/LABA/ICS
por: Buhl, Roland, et al.
Publicado: (2023)

Treatment response in COPD: does FEV(1) say it all? A post hoc analysis of the CRYSTAL study
por: Kostikas, Konstantinos, et al.
Publicado: (2019)

Le protocole d’accord revisité pour atténuer les pertes des LBM
por: Benaderette, Serge
Publicado: (2020)

Determinants of healthcare utilization and costs in COPD patients: first longitudinal results from the German COPD cohort COSYCONET
por: Byng, Danalyn, et al.
Publicado: (2019)

Real-World Treatment of Patients Newly Diagnosed with Chronic Obstructive Pulmonary Disease: A Retrospective German Claims Data Analysis
por: Buhl, Roland, et al.
Publicado: (2022)

Exacerbations of COPD
por: Viniol, Christian, et al.
Publicado: (2018)

What patients really think about asthma guidelines: barriers to guideline implementation from the patients’ perspective
por: Lingner, H., et al.
Publicado: (2017)

Impact of the COVID-19 pandemic on the behaviour and health status of patients with COPD: results from the German COPD cohort COSYCONET
por: Kahnert, Kathrin, et al.
Publicado: (2021)

Adherence To Respiratory And Nonrespiratory Medication In Patients With COPD: Results Of The German COSYCONET Cohort
por: Königsdorfer, Norbert, et al.
Publicado: (2019)

The contribution of symptoms and comorbidities to the economic impact of COPD: an analysis of the German COSYCONET cohort
por: Wacker, Margarethe E, et al.
Publicado: (2017)

Indacaterol/glycopyrronium reduces the risk of clinically important deterioration after direct switch from baseline therapies in patients with moderate COPD: a post hoc analysis of the CRYSTAL study
por: Greulich, Timm, et al.
Publicado: (2018)

Systemic steroids in COPD-the beauty and the beast
por: Vogelmeier, Claus F
Publicado: (2014)

The impact of COPD on polyneuropathy: results from the German COPD cohort COSYCONET
por: Kahnert, K., et al.
Publicado: (2020)

CHIS/F07-Demande d'accord préalable : Transport / Moyens auxiliaires / Chirurgie réfractive / Infertilité
por: Wanert-Calaga, Sophie Marie
Publicado: (2022)

CHIS/F06-Demande d'accord préalable : frais de cure/séjours de convalescence
por: Wanert-Calaga, Sophie Marie, et al.
Publicado: (2020)

COPD Exacerbation History and Impact on Future Exacerbations – 8-Year Retrospective Observational Database Cohort Study from Germany
por: Vogelmeier, Claus F, et al.
Publicado: (2021)

Comorbid Influences on Generic Health-Related Quality of Life in COPD: A Systematic Review
por: Huber, Manuel B., et al.
Publicado: (2015)

Transfer factor for carbon monoxide in patients with COPD and diabetes: results from the German COSYCONET cohort
por: Kahnert, Kathrin, et al.
Publicado: (2017)

COPD & COVID-19
por: Halpin, David M.G., et al.
Publicado: (2021)

COPD & COVID-19
por: Halpin, David M.G., et al.
Publicado: (2021)

Psychometric properties of the German version of the Leicester Cough Questionnaire in sarcoidosis
por: Schupp, Jonas Christian, et al.
Publicado: (2018)

Effets des Forces de Lorentz et Système d'Accord en Fréquence pour les Cavités à Protons
por: Gassot, H, et al.
Publicado: (2001)

Dispositif de pilotage du courant d'accord de groupe des systemes RF 10 MHz du PS
por: Maesen, P
Publicado: (1990)

Influence of body mass on predicted values of static hyperinflation in COPD
por: Alter, Peter, et al.
Publicado: (2018)

Highlights and hot topics in the management of COPD: where are we heading?
por: Agustí, Alvar, et al.
Publicado: (2016)

Perception of symptoms and quality of life – comparison of patients’ and physicians’ views in the COPD MIRROR study
por: Celli, Bartolome, et al.
Publicado: (2017)

Tiotropium and Salmeterol in COPD Patients at Risk of Exacerbations: A Post Hoc Analysis from POET-COPD(®)
por: Vogelmeier, Claus F., et al.
Publicado: (2015)

Assessing health-related quality of life in COPD: comparing generic and disease-specific instruments with focus on comorbidities
por: Wacker, Margarethe E., et al.
Publicado: (2016)

Effectiveness of Extrafine Single Inhaler Triple Therapy in Chronic Obstructive Pulmonary Disease (COPD) in Germany – The TriOptimize Study
por: Gessner, Christian, et al.
Publicado: (2022)

Système d'accord des unités d'accélération du synchrotron injecteur (Booster): Mesures sur une cavité d'essai
por: Zanaschi, D
Publicado: (1968)

Cannot write session to /tmp/vufind_sessions/sess_dhfbvdehkvgglnn1uoqac6vdh6